Last update April 17, 2016

Пинаверия Бромид

Low Risk

Moderately safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.

A Calcium channel blocker with spasmolytic activity on the intestine and antimuscarinic effects.

At latest update no published data were found on excretion into breast milk.
Pharmacokinetic data (moderately high molecular weight and high protein binding) make unlikely the passage into milk in significant amounts.
Its low oral bioavailability hinders its passage into infant's plasma from ingested milk, except in preterm infants and immediate neonatal period, since they may exhibit an increased intestinal permeability.

Anticholinergics may reduce milk production: take a minimum necessary dose and avoid prolonged treatment if decreased milk is observed.


We do not have alternatives for Пинаверия Бромид.

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Пинаверия Бромид is Pinaverium Bromide in Cyrillic.

Is written in other languages:


Пинаверия Бромид belongs to this group or family:


Main tradenames from several countries containing Пинаверия Бромид in its composition:


Variable Value Unit
Oral Bioavail. 1 %
Molecular weight 591 daltons
Protein Binding 97 %
Tmax 1 hours
1.5 hours


  1. BGP. Pinaverium. Product Monograph. 2015 Full text (in our servers)
  2. Annaházi A, Róka R, Rosztóczy A, Wittmann T. Role of antispasmodics in the treatment of irritable bowel syndrome. World J Gastroenterol. 2014 Abstract
  3. AEMPS. Pinaverio. Ficha técnica. 2014 Full text (in our servers)

Total visits


Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at

e-lactancia is a resource recommended by AELAMA of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM